首页 > 最新文献

Japanese Journal of Cancer and Chemotherapy最新文献

英文 中文
Enhanced Germinal Center Reactions Within Tertiary Lymphoid Structures Following Neoadjuvant Chemotherapy and Intestinal Care-A Path to Robust Antitumor Immune Response in Borderline Resectable Pancreatic Ductal Adenocarcinoma. 新辅助化疗和肠道护理后三级淋巴结构内的生发中心反应增强--边界可切除胰腺导管腺癌的强大抗肿瘤免疫反应之路
Q4 Medicine Pub Date : 2024-10-01
Tetsuo Ohta, Isamu Makino, Mitsuyoshi Okazaki, Shintaro Yagi

Background: In 2019, 4 patients with borderline resectable-pancreatic ductal adenocarcinoma(BR-PDAC)received neoadjuvant chemotherapy(NAC)with 3 cycles of gemcitabine plus nab-paclitaxel(GnP)over 12 weeks in combination with intestinal care, and subsequently underwent pancreatectomy. Surprisingly, histological response to NAC was Grade 3(viable tumor cells <10%)in 3 out of 4 patients. Aim/subjects: This study aimed to clarify the histopathological findings common to 3 patients with Grade 3 histological response to NAC.

Results: Common histopathological findings were as follows: 1)each tumor bed was extensively replaced by fibrous connective tissues with a high degree of inflammatory cell infiltration, and almost no viable cancer cells were observed; 2)all cancer cells within the perineural space where perineural invasion is usually seen, had undergone cytolysis; 3)tertiary lymphoid structures(TLSs)with germinal centers were found at the periphery of each tumor bed, and many plasma cells were seen adjacent to TLSs; and 4)a lot of tingible body macrophages that phagocytosed apoptotic B cells were present around germinal center.

Conclusions: NAC with 3 cycles of GnP over 12 weeks in combination with intestinal care elicited a potent antitumor immune response through enhanced germinal center reactions within TLSs.

背景:2019年,4名边界可切除胰腺导管腺癌(BR-PDAC)患者接受了吉西他滨+纳布-紫杉醇(GnP)3个周期、为期12周的新辅助化疗(NAC),并结合肠道护理,随后接受了胰腺切除术。令人惊讶的是,患者对 NAC 的组织学反应为 3 级(肿瘤细胞存活):常见的组织病理学结果如下:1)每个瘤床都被纤维结缔组织广泛取代,并伴有高度的炎性细胞浸润,几乎没有观察到存活的癌细胞;2)通常可见的神经周围侵犯的神经周围间隙内的所有癌细胞都已被细胞溶解;3)在每个瘤床的外围都发现了带有生发中心的三级淋巴结构(TLSs),TLSs 附近可见大量浆细胞;4)在生发中心周围存在大量吞噬凋亡 B 细胞的可定型体巨噬细胞。结论12周内使用3个周期GnP的NAC与肠道护理相结合,可通过增强TLS内的生发中心反应引起有效的抗肿瘤免疫反应。
{"title":"Enhanced Germinal Center Reactions Within Tertiary Lymphoid Structures Following Neoadjuvant Chemotherapy and Intestinal Care-A Path to Robust Antitumor Immune Response in Borderline Resectable Pancreatic Ductal Adenocarcinoma.","authors":"Tetsuo Ohta, Isamu Makino, Mitsuyoshi Okazaki, Shintaro Yagi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>In 2019, 4 patients with borderline resectable-pancreatic ductal adenocarcinoma(BR-PDAC)received neoadjuvant chemotherapy(NAC)with 3 cycles of gemcitabine plus nab-paclitaxel(GnP)over 12 weeks in combination with intestinal care, and subsequently underwent pancreatectomy. Surprisingly, histological response to NAC was Grade 3(viable tumor cells <10%)in 3 out of 4 patients. Aim/subjects: This study aimed to clarify the histopathological findings common to 3 patients with Grade 3 histological response to NAC.</p><p><strong>Results: </strong>Common histopathological findings were as follows: 1)each tumor bed was extensively replaced by fibrous connective tissues with a high degree of inflammatory cell infiltration, and almost no viable cancer cells were observed; 2)all cancer cells within the perineural space where perineural invasion is usually seen, had undergone cytolysis; 3)tertiary lymphoid structures(TLSs)with germinal centers were found at the periphery of each tumor bed, and many plasma cells were seen adjacent to TLSs; and 4)a lot of tingible body macrophages that phagocytosed apoptotic B cells were present around germinal center.</p><p><strong>Conclusions: </strong>NAC with 3 cycles of GnP over 12 weeks in combination with intestinal care elicited a potent antitumor immune response through enhanced germinal center reactions within TLSs.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"1038-1043"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142688751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Upper Gastrointestinal Perforation during Treatment with Regorafenib for Recurrent Rectal Cancer]. [瑞戈非尼治疗复发性直肠癌期间上消化道穿孔病例]。
Q4 Medicine Pub Date : 2024-10-01
Suzue Yoshizawa, Keisuke Kazama, Kazuki Otani, Itaru Hashimoto, Aya Kato, Yukio Maezawa, Sho Sawazaki, Toru Aoyama, Norio Yukawa, Aya Saito, Yasushi Rino

A 58-year-old man was treated with radical excision for rectal cancer. Pathological findings were pT3N1M0, Stage ⅢB, RAS: mutant, BRAF: mutant, MSS. The patient was followed up without adjuvant chemotherapy. Eight months after surgery, a CT scan showed recurrence of liver metastases, and chemotherapy was started. The patient was started on regorafenib as the fourth-line therapy for multiple liver metastases, distant lymph node metastases, and peritoneal dissemination. Twenty-three days after the first course, he developed severe abdominal pain and visited the emergency department on day 25. Suspecting generalized peritonitis due to perforation of the upper gastrointestinal tract, he was treated with emergency laparotomy and drainage. A perforation was found in the anterior wall of the lower gastrointestinal body and was sutured closed. There were no adverse events, and the patient was discharged on the 21st postoperative day. regorafenib is a multi-kinase inhibitor, and gastrointestinal perforation has been reported as a serious adverse event, although it is rare. We report a case of upper gastrointestinal perforation during regorafenib administration, with some discussion of the literature.

一名 58 岁的男性接受了直肠癌根治术。病理结果为 pT3N1M0,ⅢB 期,RAS:突变,BRAF:突变,MSS。患者术后未接受辅助化疗。术后 8 个月,CT 扫描显示肝转移灶复发,于是开始化疗。患者开始接受瑞戈非尼作为四线治疗,以治疗多发性肝转移、远处淋巴结转移和腹膜播散。第一个疗程结束 23 天后,他出现剧烈腹痛,并于第 25 天前往急诊科就诊。由于怀疑是上消化道穿孔引起的全身腹膜炎,他接受了急诊开腹手术和引流术。在下胃肠道体的前壁发现了一个穿孔,并进行了缝合。瑞戈非尼是一种多激酶抑制剂,胃肠道穿孔作为一种严重的不良反应已有报道,但并不多见。我们报告了一例在服用瑞戈非尼期间发生上消化道穿孔的病例,并对文献进行了一些讨论。
{"title":"[A Case of Upper Gastrointestinal Perforation during Treatment with Regorafenib for Recurrent Rectal Cancer].","authors":"Suzue Yoshizawa, Keisuke Kazama, Kazuki Otani, Itaru Hashimoto, Aya Kato, Yukio Maezawa, Sho Sawazaki, Toru Aoyama, Norio Yukawa, Aya Saito, Yasushi Rino","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 58-year-old man was treated with radical excision for rectal cancer. Pathological findings were pT3N1M0, Stage ⅢB, RAS: mutant, BRAF: mutant, MSS. The patient was followed up without adjuvant chemotherapy. Eight months after surgery, a CT scan showed recurrence of liver metastases, and chemotherapy was started. The patient was started on regorafenib as the fourth-line therapy for multiple liver metastases, distant lymph node metastases, and peritoneal dissemination. Twenty-three days after the first course, he developed severe abdominal pain and visited the emergency department on day 25. Suspecting generalized peritonitis due to perforation of the upper gastrointestinal tract, he was treated with emergency laparotomy and drainage. A perforation was found in the anterior wall of the lower gastrointestinal body and was sutured closed. There were no adverse events, and the patient was discharged on the 21st postoperative day. regorafenib is a multi-kinase inhibitor, and gastrointestinal perforation has been reported as a serious adverse event, although it is rare. We report a case of upper gastrointestinal perforation during regorafenib administration, with some discussion of the literature.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"1080-1082"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Laparoscopic Surgery for Malignant Lymphoma of the Small Intestine with Bowel Obstruction]. [腹腔镜手术治疗伴有肠梗阻的小肠恶性淋巴瘤一例]。
Q4 Medicine Pub Date : 2024-10-01
Naohiko Otsuka, Ouki Yasui, Wataru Iwasaki, Yujiro Kato, Teiji Takahashi

An 80-year-old woman presented to our hospital complaining of nausea and abdominal distention. An abdominal computed tomography scan revealed wall thickening of the small intestine, a dilated oral intestinal tract, swollen intra-abdominal lymph nodes, and splenomegaly. Moreover, the soluble interleukin-2 receptor level was increased at 2,120 U/mL. Accordingly, we diagnosed the patient with a small bowel obstruction due to malignant lymphoma of the small intestine, for which we performed a laparoscopy-assisted partial resection of the small intestine after decompression. The resected specimen was pathologically diagnosed as diffuse large B-cell lymphoma. The patient's general condition recovered rapidly after laparoscopic surgery, and her clinical course proceeded smoothly to the initiation of chemotherapy(R-CHOP)at the Department of Hematology. The tumor remains in remission now. Here, we report a case of laparoscopic surgery for malignant lymphoma of the small intestine that caused bowel obstruction due to luminal narrowing along with a relevant literature review.

一名 80 岁的妇女来到我院就诊,主诉恶心和腹胀。腹部计算机断层扫描显示小肠壁增厚、口腔肠道扩张、腹腔内淋巴结肿大和脾脏肿大。此外,可溶性白细胞介素-2 受体水平升高至 2 120 U/mL。因此,我们诊断患者为小肠恶性淋巴瘤导致的小肠梗阻,并在减压后为其实施了腹腔镜辅助下的小肠部分切除术。切除标本经病理诊断为弥漫大 B 细胞淋巴瘤。腹腔镜手术后,患者全身情况迅速恢复,临床过程顺利,并在血液科开始接受化疗(R-CHOP)。目前肿瘤仍处于缓解期。在此,我们报告了一例腹腔镜手术治疗小肠恶性淋巴瘤的病例,该手术因管腔狭窄而导致肠梗阻,并对相关文献进行了综述。
{"title":"[A Case of Laparoscopic Surgery for Malignant Lymphoma of the Small Intestine with Bowel Obstruction].","authors":"Naohiko Otsuka, Ouki Yasui, Wataru Iwasaki, Yujiro Kato, Teiji Takahashi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An 80-year-old woman presented to our hospital complaining of nausea and abdominal distention. An abdominal computed tomography scan revealed wall thickening of the small intestine, a dilated oral intestinal tract, swollen intra-abdominal lymph nodes, and splenomegaly. Moreover, the soluble interleukin-2 receptor level was increased at 2,120 U/mL. Accordingly, we diagnosed the patient with a small bowel obstruction due to malignant lymphoma of the small intestine, for which we performed a laparoscopy-assisted partial resection of the small intestine after decompression. The resected specimen was pathologically diagnosed as diffuse large B-cell lymphoma. The patient's general condition recovered rapidly after laparoscopic surgery, and her clinical course proceeded smoothly to the initiation of chemotherapy(R-CHOP)at the Department of Hematology. The tumor remains in remission now. Here, we report a case of laparoscopic surgery for malignant lymphoma of the small intestine that caused bowel obstruction due to luminal narrowing along with a relevant literature review.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"1017-1019"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Hepatocellular Carcinoma Relapse in the Lungs 17 Years after Liver Resection]. [肝切除术后 17 年肺部肝细胞癌复发病例]。
Q4 Medicine Pub Date : 2024-10-01
Ouki Yasui, Ikuo Matsuzaki, Masayo Murakami, Hiroshi Nanjo

A 77-year-old man underwent a right hemihepatectomy for hepatocellular carcinoma in 2002. The patient remained alive without recurrence for 17 years after surgery. In September 2019, he was diagnosed with a tumor in the lower lobe of the right lung by follow-up CT. A partial right lung resection was performed in February 2020. Histological and immunohistochemical staining confirmed the recurrence of a previous hepatocellular carcinoma. Late lung cancer recurrence after radical hepatectomy is rare. Here, we report a case of hepatocellular carcinoma relapse in the lungs 17 years after liver resection.

一名 77 岁的男性于 2002 年因肝细胞癌接受了右半肝切除术。术后 17 年,患者一直存活且未复发。2019 年 9 月,他通过随访 CT 诊断出右肺下叶肿瘤。2020 年 2 月,他接受了右肺部分切除术。组织学和免疫组化染色证实了之前的肝细胞癌复发。根治性肝切除术后肺癌晚期复发非常罕见。在此,我们报告了一例肝切除术后17年肺部肝细胞癌复发的病例。
{"title":"[A Case of Hepatocellular Carcinoma Relapse in the Lungs 17 Years after Liver Resection].","authors":"Ouki Yasui, Ikuo Matsuzaki, Masayo Murakami, Hiroshi Nanjo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 77-year-old man underwent a right hemihepatectomy for hepatocellular carcinoma in 2002. The patient remained alive without recurrence for 17 years after surgery. In September 2019, he was diagnosed with a tumor in the lower lobe of the right lung by follow-up CT. A partial right lung resection was performed in February 2020. Histological and immunohistochemical staining confirmed the recurrence of a previous hepatocellular carcinoma. Late lung cancer recurrence after radical hepatectomy is rare. Here, we report a case of hepatocellular carcinoma relapse in the lungs 17 years after liver resection.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"1021-1024"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer]. [胰腺癌患者精准医疗的最新课题]。
Q4 Medicine Pub Date : 2024-10-01
Shigetsugu Takano, Takanori Konishi, Tsukasa Takayashiki, Daisuke Suzuki, Nozomu Sakai, Isamu Hosokawa, Takashi Mishima, Hitoe Nishino, Kensuke Suzuki, Shinichiro Nakada, Masayuki Ohtsuka
{"title":"[Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer].","authors":"Shigetsugu Takano, Takanori Konishi, Tsukasa Takayashiki, Daisuke Suzuki, Nozomu Sakai, Isamu Hosokawa, Takashi Mishima, Hitoe Nishino, Kensuke Suzuki, Shinichiro Nakada, Masayuki Ohtsuka","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"996-1001"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Early Breast Cancer Treated with Adjuvant S-1 plus Endocrine Therapy-A Report of Two Cases]. [早期乳腺癌辅助 S-1 加内分泌治疗--两个病例的报告]。
Q4 Medicine Pub Date : 2024-10-01
Keita Adachi, Junko Nagae, Hitomi Kubota, Shuhei Suzuki, Tomohiro Hirano, Natsuki Saigusa, Takuo Henmi, Hisao Yagishita, Hitoshi Tsuda, Kenichi Sakurai

We report 2 cases of early breast cancer treated with adjuvant S-1 plus endocrine therapy. In case 1, a 70-year-old woman was diagnosed with right breast cancer and underwent partial mastectomy. The histopathological diagnosis was invasive ductal carcinoma(solid type), positive for estrogen receptor(ER)and progesterone receptor(PgR), negative for HER2/neu. The Ki-67 labeling index was 14%. The diameter of invasion was 27 mm, no lymph node metastasis was observed, and we confirmed the diagnosis as pT2N0M0, Stage ⅡA. A venous invasion was observed and the histological grade was Ⅱ. In case 2, a 53-year-old woman was diagnosed with left breast cancer and underwent lumpectomy. The histopathological findings showed a solid-tubular carcinoma, characterized by ER-positive, PgR-positive, HER2-negative. The Ki-67 labeling index was 24%. The tumor had an invasion of 20 mm and was diagnosed as Stage Ⅰ early-stage cancer, but there were some venous invasions and the histological grade was Ⅲ. We judged that both patients were at intermediate risk of recurrence and administered S-1 in addition to endocrine therapy. Even in cases without axillary lymph node metastasis, this combination of S-1 with endocrine therapy was considered to be a useful treatment option if the criteria of the POTENT trial were met.

我们报告了 2 例早期乳腺癌患者接受 S-1 加内分泌辅助治疗的病例。在病例 1 中,一名 70 岁的妇女被诊断为右侧乳腺癌,并接受了部分乳房切除术。组织病理诊断为浸润性导管癌(实体型),雌激素受体(ER)和孕激素受体(PgR)阳性,HER2/neu阴性。Ki-67标记指数为14%。浸润直径为 27 毫米,未发现淋巴结转移,确诊为 pT2N0M0,ⅡA 期。观察到静脉侵犯,组织学分级为Ⅱ级。病例 2:一名 53 岁女性被诊断为左侧乳腺癌,并接受了肿块切除术。组织病理结果显示为实性管状癌,特征为ER阳性、PgR阳性、HER2阴性。Ki-67标记指数为24%。肿瘤侵犯范围为 20 毫米,诊断为Ⅰ期早期癌,但有部分静脉侵犯,组织学分级为Ⅲ级。我们判断这两名患者都有中度复发风险,因此在内分泌治疗的基础上加用了 S-1。即使在没有腋窝淋巴结转移的病例中,如果符合 POTENT 试验的标准,S-1 与内分泌治疗的组合也被认为是一种有效的治疗方案。
{"title":"[Early Breast Cancer Treated with Adjuvant S-1 plus Endocrine Therapy-A Report of Two Cases].","authors":"Keita Adachi, Junko Nagae, Hitomi Kubota, Shuhei Suzuki, Tomohiro Hirano, Natsuki Saigusa, Takuo Henmi, Hisao Yagishita, Hitoshi Tsuda, Kenichi Sakurai","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We report 2 cases of early breast cancer treated with adjuvant S-1 plus endocrine therapy. In case 1, a 70-year-old woman was diagnosed with right breast cancer and underwent partial mastectomy. The histopathological diagnosis was invasive ductal carcinoma(solid type), positive for estrogen receptor(ER)and progesterone receptor(PgR), negative for HER2/neu. The Ki-67 labeling index was 14%. The diameter of invasion was 27 mm, no lymph node metastasis was observed, and we confirmed the diagnosis as pT2N0M0, Stage ⅡA. A venous invasion was observed and the histological grade was Ⅱ. In case 2, a 53-year-old woman was diagnosed with left breast cancer and underwent lumpectomy. The histopathological findings showed a solid-tubular carcinoma, characterized by ER-positive, PgR-positive, HER2-negative. The Ki-67 labeling index was 24%. The tumor had an invasion of 20 mm and was diagnosed as Stage Ⅰ early-stage cancer, but there were some venous invasions and the histological grade was Ⅲ. We judged that both patients were at intermediate risk of recurrence and administered S-1 in addition to endocrine therapy. Even in cases without axillary lymph node metastasis, this combination of S-1 with endocrine therapy was considered to be a useful treatment option if the criteria of the POTENT trial were met.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"1065-1067"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ⅰ. The Trend of Precision Medicine in Treatment of Hepatocellular Carcinoma]. [肝细胞癌治疗中的精准医学趋势]。
Q4 Medicine Pub Date : 2024-10-01
Junichi Arita, Shuhei Chida, Misato Horie, Naohiko Otsuka, Kimihiko Sato, Shinichiro Atsumi, Yasuhiko Nakagawa, Go Watanabe
{"title":"[Ⅰ. The Trend of Precision Medicine in Treatment of Hepatocellular Carcinoma].","authors":"Junichi Arita, Shuhei Chida, Misato Horie, Naohiko Otsuka, Kimihiko Sato, Shinichiro Atsumi, Yasuhiko Nakagawa, Go Watanabe","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"985-988"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cases of Malnutrition and Vitamin B1 Deficiency after Gastrointestinal Cancer Surgery]. [胃肠道癌症手术后营养不良和维生素 B1 缺乏病例]。
Q4 Medicine Pub Date : 2024-10-01
Junji Kawada, Minami Maruyama, Yoshitaka Okauchi, Tomonori Nomura, Yuji Ikeda, Manatsu Mizuno, Satoshi Eguchi, Yoshiki Taniguchi, Hiromitsu Hoshino, Shinya Yamashita, Hitoshi Mizuno, Yo Sasaki

We experienced cases of malnutrition and vitamin B1 deficiency after gastrointestinal cancer surgery, but they had a good course after vitamin B1 administration. Case 1 is a woman in her 70s who underwent laparoscopic distal gastrectomy for gastric cancer 2 months ago. While under outpatient observation, she was found collapsed at home and urgently brought to the hospital. She lost 3 kg of body weight in 2 weeks and was able to take in oral intake by giving fluids for malnutrition, but was unable to sit up unaided. During the course of hospitalization, vitamin B1 deficiency was reported, and vitamin B1 administration was started, which enabled her to walk independently. Case 2 is a man in her 50s who underwent video-assisted thoracic esophagectomy for esophageal cancer approximately 1 year ago. He was urgently brought to the hospital due to decreased oral intake due to alcohol dependence. 17.1 kg/m2 BMI, malnutrition, 67/40 mmHg blood pressure, and decreased left ventricular septal wall motion were observed. Vitamin B1 deficiency due to alcohol dependence was suspected, so vitamin B1 administration was started, and blood pressure increased within a few hours.

我们曾遇到过胃肠道癌症术后营养不良和维生素 B1 缺乏的病例,但在服用维生素 B1 后,他们的病情得到了很好的控制。病例 1 是一位 70 多岁的妇女,2 个月前因胃癌接受了腹腔镜远端胃切除术。在门诊观察期间,她被发现在家中昏倒,被紧急送往医院。她在两周内体重减轻了 3 公斤,因营养不良输液后可以口服,但无法独立坐起。在住院期间,她被报告缺乏维生素 B1,于是开始服用维生素 B1,这使她能够独立行走。病例 2 是一名 50 多岁的男性,大约 1 年前因食道癌接受了视频辅助胸腔食道切除术。由于酒精依赖导致口服量减少,他被紧急送入医院。他的体重指数(BMI)为 17.1 kg/m2,营养不良,血压为 67/40 mmHg,左室间隔壁运动减弱。怀疑酒精依赖导致维生素 B1 缺乏,因此开始服用维生素 B1,血压在几小时内有所上升。
{"title":"[Cases of Malnutrition and Vitamin B1 Deficiency after Gastrointestinal Cancer Surgery].","authors":"Junji Kawada, Minami Maruyama, Yoshitaka Okauchi, Tomonori Nomura, Yuji Ikeda, Manatsu Mizuno, Satoshi Eguchi, Yoshiki Taniguchi, Hiromitsu Hoshino, Shinya Yamashita, Hitoshi Mizuno, Yo Sasaki","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We experienced cases of malnutrition and vitamin B1 deficiency after gastrointestinal cancer surgery, but they had a good course after vitamin B1 administration. Case 1 is a woman in her 70s who underwent laparoscopic distal gastrectomy for gastric cancer 2 months ago. While under outpatient observation, she was found collapsed at home and urgently brought to the hospital. She lost 3 kg of body weight in 2 weeks and was able to take in oral intake by giving fluids for malnutrition, but was unable to sit up unaided. During the course of hospitalization, vitamin B1 deficiency was reported, and vitamin B1 administration was started, which enabled her to walk independently. Case 2 is a man in her 50s who underwent video-assisted thoracic esophagectomy for esophageal cancer approximately 1 year ago. He was urgently brought to the hospital due to decreased oral intake due to alcohol dependence. 17.1 kg/m2 BMI, malnutrition, 67/40 mmHg blood pressure, and decreased left ventricular septal wall motion were observed. Vitamin B1 deficiency due to alcohol dependence was suspected, so vitamin B1 administration was started, and blood pressure increased within a few hours.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"1074-1076"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Introduction of Online Genetic Counseling for Hereditary Tumors Using an Online Medical Consultation Application]. [利用在线医疗咨询应用程序引入遗传性肿瘤在线遗传咨询]。
Q4 Medicine Pub Date : 2024-10-01
Takeshi Nakajima

Online medicine has become more common since the COVID-19 pandemic, but there are few cases of hospitals introducing online genetic counseling(OGC)in Japan. We introduced the online medical consultation application at 2 medical institutions for OGC. Genetic counseling for hereditary tumors will need to be broadened and implemented widely. Using the application makes it easy to make and complete reservations. OGC, which can reduce the time and space burden on clients, is a promising option of genetic counseling. It is hoped that OGC will become more widespread as a form of genetic medicine in the future, so that a limited number of genetic specialists can respond to a wide range of needs. In order to increase the number of users in the future, it is necessary to 1)raise awareness among the general public through public relations activities, and 2)collaborate with medical facilities that do not have specialized outpatient clinics for hereditary tumors.

自 COVID-19 大流行以来,在线医疗变得越来越普遍,但在日本,医院引入在线遗传咨询(OGC)的案例却很少。我们在两家医疗机构引进了在线医疗咨询应用程序,用于 OGC。遗传性肿瘤的遗传咨询需要扩大范围并广泛实施。使用该应用程序可以轻松完成预约。OGC 可以减轻客户在时间和空间上的负担,是一种很有前景的遗传咨询方式。希望 OGC 作为遗传医学的一种形式,今后能得到更广泛的应用,从而使有限的遗传专家能满足广泛的需求。为了在未来增加用户数量,有必要:1)通过公关活动提高公众的认识;2)与没有遗传性肿瘤专科门诊的医疗机构合作。
{"title":"[Introduction of Online Genetic Counseling for Hereditary Tumors Using an Online Medical Consultation Application].","authors":"Takeshi Nakajima","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Online medicine has become more common since the COVID-19 pandemic, but there are few cases of hospitals introducing online genetic counseling(OGC)in Japan. We introduced the online medical consultation application at 2 medical institutions for OGC. Genetic counseling for hereditary tumors will need to be broadened and implemented widely. Using the application makes it easy to make and complete reservations. OGC, which can reduce the time and space burden on clients, is a promising option of genetic counseling. It is hoped that OGC will become more widespread as a form of genetic medicine in the future, so that a limited number of genetic specialists can respond to a wide range of needs. In order to increase the number of users in the future, it is necessary to 1)raise awareness among the general public through public relations activities, and 2)collaborate with medical facilities that do not have specialized outpatient clinics for hereditary tumors.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"977-981"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Liver, Pancreas, Biliary Tract Cancer The Recent Progress and Clinical Implications of Tumor Biomarkers in Hepatobiliary Pancreatic Malignancies]. [肝、胰、胆道癌症 肝胆胰恶性肿瘤中肿瘤生物标志物的最新进展和临床意义]。
Q4 Medicine Pub Date : 2024-10-01
Masaru Miyazaki
{"title":"[Liver, Pancreas, Biliary Tract Cancer The Recent Progress and Clinical Implications of Tumor Biomarkers in Hepatobiliary Pancreatic Malignancies].","authors":"Masaru Miyazaki","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 10","pages":"982-984"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Japanese Journal of Cancer and Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1